FCX vs PRTA · P/E 38, rev $25.45B vs rev $9.7M
Freeport-McMoran Copper & Gold Inc (FCX) versus Prothena Corporation plc (PRTA) — a side-by-side from cached financials, not a winner call.
Freeport-McMoran Copper & Gold Inc (FCX) is a copper company listed on US.
Prothena Corporation plc (PRTA) is a biotechnology company listed on US.
Latest reported FCX revenue for 2024-12-31 was $25.45B. Net income was $4.40B. Revenue was up 11.4% from 2023-12-31 to 2024-12-31. FCX currently screens at market cap $67.80B and trailing P/E 38.0.
Latest reported PRTA revenue for 2025-12-31 was $9.7M. Net income was -$244.1M. Revenue was down 92.8% from 2024-12-31 to 2025-12-31. PRTA currently screens at market cap $460.2M.
FCX currently screens at market cap $67.80B and trailing P/E 38.0. PRTA currently screens at market cap $460.2M.
Not investment advice. Open the FCX and PRTA stock pages for the full models.
Not investment advice.